TY - CHAP AU - Faunce, T. A. ED - Bennett, B. ED - Tomossy, G. F. PY - 2005 DA - 2005// TI - 'Global Intellectual Property Protection for Innovative Pharmaceuticals: Challenges for Bioethics and Health Law' BT - Globalisation and Health PB - Springer. Dordrecht CY - USA ID - Faunce2005 ER - TY - JOUR AU - Moghimi, S. M. AU - Hunter, A. C. AU - Murray, J. C. PY - 2005 DA - 2005// TI - 'Nanomedicine: Current Status and Future Prospects' JO - FASEB Journal VL - 19 UR - https://doi.org/10.1096/fj.04-2747rev DO - 10.1096/fj.04-2747rev ID - Moghimi2005 ER - TY - JOUR AU - Neumann, P. J. AU - Rosen, A. B. AU - Weinstein, M. C. PY - 2005 DA - 2005// TI - 'Medicare and Cost-Effectiveness Analysis' JO - New England Journal of Medicine VL - 353 UR - https://doi.org/10.1056/NEJMsb050564 DO - 10.1056/NEJMsb050564 ID - Neumann2005 ER - TY - CHAP AU - Berger PY - 2003 DA - 2003// BT - Health Care Cost, Quality and Outcomes PB - International Society for Pharmacoeconomics and Outcomes Research CY - Lawrenceville NJ ID - Berger2003 ER - TY - CHAP AU - Berger PY - 2003 DA - 2003// BT - Health Care Cost, Quality and Outcomes PB - International Society for Pharmacoeconomics and Outcomes Research, Lawrenceville NJ. European Economic Community, Medical Device Directive Council Directive 93/42/EEC CY - Lawrenceville NJ ID - Berger2003 ER - TY - CHAP AU - Berger PY - 2003 DA - 2003// BT - Health Care Cost, Quality and Outcomes PB - International Society for Pharmacoeconomics and Outcomes Research CY - Lawrenceville NJ ID - Berger2003 ER - TY - JOUR AU - Henry, D. A. AU - Hill, S. R. AU - Harris, A. PY - 2005 DA - 2005// TI - Drug prices and value for money. The Australian Pharmaceutical Benefits Scheme' JO - Journal of the American Medical Association VL - 294 UR - https://doi.org/10.1001/jama.294.20.2630 DO - 10.1001/jama.294.20.2630 ID - Henry2005 ER - TY - CHAP AU - Pammolli, F. PY - 2005 DA - 2005// TI - Medical devices Competitiveness and Impact on Public Health Expenditure BT - Directorate Entreprise of the European Commission University of Florence ID - Pammolli2005 ER - TY - JOUR AU - Ray, W. A. AU - Stein, C. M. PY - 2006 DA - 2006// TI - 'Reform of drug regulation-Beyond an Independent Drug-Safety Board' JO - New England Journal of Medicine VL - 354 UR - https://doi.org/10.1056/NEJMsb053432 DO - 10.1056/NEJMsb053432 ID - Ray2006 ER - TY - CHAP PY - 2006 DA - 2006// BT - Working Towards Harmonization in Medical Device Regulation ID - ref10 ER - TY - CHAP AU - Bloor, K. AU - Maynard, A. ED - Drummond, M. F. ED - Maynard, A. PY - 1993 DA - 1993// TI - 'Cost-Effective Prescribing of Pharmaceuticals: The Search for the Holy Grail,' BT - Purchasing and Providing Cost-Effective Health Care PB - Churchill Livingstone CY - London ID - Bloor1993 ER - TY - JOUR AU - Birkett, D. J. AU - Mitchell, A. S. AU - McManus, P. PY - 2001 DA - 2001// TI - A Cost-Effectiveness Approach to Drug Subsidy and Pricing in Australia JO - Health Affairs VL - 20 UR - https://doi.org/10.1377/hlthaff.20.3.104 DO - 10.1377/hlthaff.20.3.104 ID - Birkett2001 ER - TY - JOUR AU - Day, R. O. AU - Birkett, D. J. AU - Miners, J. AU - Shenfield, G. M. AU - Henry, D. A. AU - Seale, J. P. PY - 2005 DA - 2005// TI - 'Access to medicines and high-quality therapeutics: global responsibilities for clinical pharmacology JO - Medical Journal of Australia VL - 182 ID - Day2005 ER - TY - STD TI - Australian Government Department of Health and Ageing: National Medicines Policy.[http://www.health.gov.au/internet/wcms/publishing.nsf/Content/nmp-objectives-policy.htm] UR - http://www.health.gov.au/internet/wcms/publishing.nsf/Content/nmp-objectives-policy.htm ID - ref14 ER - TY - STD TI - Interviews by the author with PBAC members in 2005. ID - ref15 ER - TY - STD TI - New Zealand Pharmaceutical Management Agency2005. [http://www.pharmac.govt.nz/whoarepharmac.asp] UR - http://www.pharmac.govt.nz/whoarepharmac.asp ID - ref16 ER - TY - JOUR AU - Detsky, A. PY - 1993 DA - 1993// TI - 'Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada.' JO - Pharmacoeconomics VL - 3 UR - https://doi.org/10.2165/00019053-199303050-00003 DO - 10.2165/00019053-199303050-00003 ID - Detsky1993 ER - TY - JOUR AU - Morgan, S. AU - Bassett, K. AU - Mintzes, B. PY - 2004 DA - 2004// TI - Outcomes-Based Drug Coverage in British Columbia' JO - Health Affairs VL - 23 UR - https://doi.org/10.1377/hlthaff.23.3.269 DO - 10.1377/hlthaff.23.3.269 ID - Morgan2004 ER - TY - STD TI - Canadian Coordinating Office for Health Technology AssessmentInterviews by the author with CEDAC officials in 2005 last accessed 12 Dec 2005 [https://www.ccohta.ca/CDR/cdr_committees_e.cfm] UR - https://www.ccohta.ca/CDR/cdr_committees_e.cfm ID - ref19 ER - TY - STD TI - Canadian Patented Medicines Prices Review Board2005. [http://www.pmprb-cepmb.gc.ca/english/view.asp?x=272#2] UR - http://www.pmprb-cepmb.gc.ca/english/view.asp?x=272#2 ID - ref20 ER - TY - STD TI - Interviews by the author with PMPRB senior officials in Ottawa 2005. ID - ref21 ER - TY - STD TI - European Medicines Agency website2005. [http://www.emea.eu.int/sitemap.htm] UR - http://www.emea.eu.int/sitemap.htm ID - ref22 ER - TY - CHAP AU - Dickson, J. AU - Hurst, J. AU - Jacobzone, S. PY - 2003 DA - 2003// TI - Survey of pharmacoeconomic assessment activity in eleven countries BT - Directorate for Employment, labor and Social Affairs, OECD Health Working Papers No4, Organisation for Economic Co-Operation and Development ID - Dickson2003 ER - TY - JOUR AU - Taylor, R. S. AU - Drummond, M. F. AU - Salkeld, G. AU - Sullivan, S. D. PY - 2004 DA - 2004// TI - 'Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle' JO - British Medical Journal VL - 329 UR - https://doi.org/10.1136/bmj.329.7472.972 DO - 10.1136/bmj.329.7472.972 ID - Taylor2004 ER - TY - CHAP AU - Kincses, G. PY - 2004 DA - 2004// BT - 'The situation of health technology assessment in Hungary.' Poster presentation. International Society for Pharmacoeconomics and Outcomes Research 2nd Asia-Pacific Conference Shanghai ID - Kincses2004 ER - TY - CHAP AU - Giuliani, G. AU - Selke, G. AU - Garattini, L. PY - 1998 DA - 1998// BT - The German Experience in Reference Pricing Health Policy ID - Giuliani1998 ER - TY - JOUR AU - Berger, M. L. PY - 2005 DA - 2005// TI - 'Cost-Effectiveness Analysis. From Science to Application.' JO - Medical Care VL - 43 ID - Berger2005 ER - TY - JOUR AU - Lipsy, R. J. PY - 1992 DA - 1992// TI - 'Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions JO - Pharmacoeconomics VL - 1 UR - https://doi.org/10.2165/00019053-199201040-00004 DO - 10.2165/00019053-199201040-00004 ID - Lipsy1992 ER - TY - STD TI - The PPRS sets each such company a set level of return on capital, which represents the amount that can be earned through sales to the National Health Service. Return on capital is calculated from 21% of a fixed asset figure in a submitted annual financial return, also taking into account the company's expenditure on research and development, marketing and provision of information. United Kingdom Pharmaceutical Price Regulation Scheme. last accessed 12 Dec 2005 [http://www.dh.gov.uk/PolicyAndGuidance/MedicinesPharmacyAndIndustry/PharmaceuticalPriceRegulationScheme/ThePPRSScheme/fs/en] UR - http://www.dh.gov.uk/PolicyAndGuidance/MedicinesPharmacyAndIndustry/PharmaceuticalPriceRegulationScheme/ThePPRSScheme/fs/en ID - ref29 ER - TY - STD TI - National Institute for Health and Clinical Excellence[http://www.nice.org.uk/page.aspx?o=home] UR - http://www.nice.org.uk/page.aspx?o=home ID - ref30 ER - TY - JOUR AU - Henry, D. A. AU - Hill, S. R. AU - Harris, A. PY - 2005 DA - 2005// TI - 'Drug Prices and Value for Money. The Australian Pharmaceutical Benefits Scheme' JO - Journal of the American Medical Association VL - 294 UR - https://doi.org/10.1001/jama.294.20.2630 DO - 10.1001/jama.294.20.2630 ID - Henry2005 ER - TY - STD TI - US Food and Drug Administratioj. Risk Management[http://www.fda.gov/oc/mcclellan/riskmngt.html] UR - http://www.fda.gov/oc/mcclellan/riskmngt.html ID - ref32 ER - TY - JOUR AU - Luce, B. R. PY - 2005 DA - 2005// TI - 'What will it take to make cost-effectiveness analysis acceptable in the United States?' JO - Medical Care VL - 43 ID - Luce2005 ER - TY - STD TI - Kamae I: 'Health economics in Japan: Dawning or Staggering?'.International Society for Pharmacoeconomics and Outcomes Research 2nd Asia-Pacific Conference Shanghai 6 March 2006 ID - ref34 ER - TY - JOUR AU - Drummond, M. AU - Sculpher, M. PY - 2005 DA - 2005// TI - 'Common methodological flaws in economic evaluations' JO - Medical Care VL - 43 ID - Drummond2005 ER - TY - JOUR AU - Soumerai, S. B. PY - 1993 DA - 1993// TI - A critical analysis of studies of state drug reimbursement policies: research in need of discipline JO - Millbank Quarterly VL - 71 UR - https://doi.org/10.2307/3350399 DO - 10.2307/3350399 ID - Soumerai1993 ER - TY - JOUR AU - Neumann, P. J. PY - 2004 DA - 2004// TI - 'Evidence-based and value-based formulary guidelines' JO - Health Affairs VL - 23 UR - https://doi.org/10.1377/hlthaff.23.1.124 DO - 10.1377/hlthaff.23.1.124 ID - Neumann2004 ER - TY - STD TI - Neumann P: 'Evidence-based policy and benefit design for health care value'.International Society for Pharmacoeconomics and Outcomes Research 2nd Asia-Pacific Conference Shanghai 6 March 2006. ID - ref38 ER - TY - JOUR AU - Berger, M. L. PY - 2005 DA - 2005// TI - Cost-effectiveness analysis. From science to application JO - Medical Care VL - 43 ID - Berger2005 ER - TY - JOUR AU - Aspinall, S. L. AU - Good, C. B. AU - Glassman, P. A. AU - Valentino, M. A. PY - 2005 DA - 2005// TI - 'The evolving use of cost-effectiveness analysis in formulary management within the department of veterans affairs' JO - Medical Care VL - 43 ID - Aspinall2005 ER - TY - CHAP AU - Hu, S. PY - 2005 DA - 2005// BT - 'Pharmacoeconomics and outcome research in China'international Society for Pharmacoeconomics and Outcomes Research 2nd Asia-Pacific Conference Shanghai ID - Hu2005 ER - TY - CHAP AU - Yang, B. -. M. PY - 2006 DA - 2006// BT - 'Use of economic evaluation in insurance decision making: South Korea'. International Society for Pharmacoeconomics and Outcomes Research 2nd Asia-Pacific Conference Shanghai ID - Yang2006 ER - TY - CHAP AU - Chuen, L. S. PY - 2006 DA - 2006// BT - 'Recent changes in the healthcare scene in Singapore'. International Society for Pharmacoeconomics and Outcomes Research 2nd Asia-Pacific Conference Shanghai ID - Chuen2006 ER - TY - CHAP AU - Tangcharoensa, V. PY - 2006 DA - 2006// BT - 'Role of pharmaco-economic in Thailand'. International Society for Pharmacoeconomics and Outcomes Research 2nd Asia-Pacific Conference Shanghai ID - Tangcharoensa2006 ER - TY - CHAP AU - Hameed, A. AU - Aljunid, S. M. PY - 2006 DA - 2006// BT - 'Pharmaco-economics and outcomes research in Pakistan''Pharmaco-economics and outcomes research in Malaysia'. International Society for Pharmacoeconomics and Outcomes Research 2nd Asia-Pacific Conference Shanghai ID - Hameed2006 ER - TY - BOOK PY - 2004 DA - 2004// TI - The World Medicines Situation PB - World Health Organisation CY - Geneva ID - ref46 ER - TY - CHAP AU - Danzon, P. M. AU - Towse, A. ED - Maskus, K. E. ED - Reichman, J. H. PY - 2005 DA - 2005// TI - Theory and implementation of differential pricing of pharmaceuticals BT - International Public Goods and Transfer of Technology Under a Globalised Intellectual Property Regime PB - Camb university Press CY - NY UR - https://doi.org/10.1017/CBO9780511494529.022 DO - 10.1017/CBO9780511494529.022 ID - Danzon2005 ER - TY - CHAP AU - Bapna, J. S. PY - 2006 DA - 2006// BT - 'Pharmaco-economics and Outcomes research in India'. International Society for Pharmacoeconomics and Outcomes Research 2nd Asia-Pacific Conference Shanghai ID - Bapna2006 ER - TY - CHAP AU - Laing, R. AU - Waning, B. AU - Gray, A. AU - Ford, N. AU - 'tHoen, E. PY - 2003 DA - 2003// TI - 25 Years of the WHO essential medicines lists: progress and challenges BT - Lancet ID - Laing2003 ER - TY - CHAP AU - Drummond, M. PY - 2006 DA - 2006// BT - 'ISPOR and the medical device world' ISPOR Asia medical device and diagnostics council forum'. International Society for Pharmacoeconomics and Outcomes Research 2nd Asia-Pacific Conference Shanghai ID - Drummond2006 ER - TY - CHAP AU - Drummond, M. PY - 2006 DA - 2006// BT - 'ISPOR and the medical device world' ISPOR Asia medical device and diagnostics council forum'. International Society for Pharmacoeconomics and Outcomes Research 2nd Asia-Pacific Conference Shanghai ID - Drummond2006 ER - TY - STD TI - Global Harmonisation Taskforce[http://www.ghtf.org/information/information.htm] UR - http://www.ghtf.org/information/information.htm ID - ref52 ER - TY - BOOK AU - Maskus, K. E. AU - Reichman, J. H. PY - 2005 DA - 2005// TI - "The Globalisation of private knowledge goods and the privatisation of global public goods" in KE Maskus and JH Reichman 2005 International Public Goods and Transfer of Technology Under a Globalised Intellectual Property regime Cambridge University Press, NY ID - Maskus2005 ER - TY - JOUR AU - Leary, V. A. PY - 1994 DA - 1994// TI - The right to health in international human rights law JO - Health and Human Rights VL - 1 UR - https://doi.org/10.2307/4065261 DO - 10.2307/4065261 ID - Leary1994 ER - TY - STD TI - World Trade Organisation: Declaration on the TRIPS agreement and public health WT/MIN(01)/DEC/2. 20 November 2001 ID - ref55 ER - TY - STD TI - UNESCO:Universal Declaration on Bioethics and Human Rights. last accessed 12 Dec 2005 [http://portal.unesco.org/shs/en/ev.php-URL_ID=1883&URL_DO=DO_TOPIC&URL_SECTION=201.html] UR - http://portal.unesco.org/shs/en/ev.php-URL_ID=1883&URL_DO=DO_TOPIC&URL_SECTION=201.html ID - ref56 ER - TY - BOOK AU - Cochrane, A. L. PY - 1972 DA - 1972// TI - Effectiveness and Efficiency: Random Reflections on Health Services London Nuffield Provincial Hospitals Trust ID - Cochrane1972 ER - TY - JOUR AU - Lopez-Casasnovas AU - Puig-Junoy PY - 2000 DA - 2000// JO - Review of the literature on reference pricing health policy 2000 VL - 54 ID - Lopez-Casasnovas2000 ER - TY - JOUR AU - Hill, S. R. AU - Mitchell, A. S. AU - Henry, D. A. PY - 2000 DA - 2000// TI - Problems with the interpretation of pharmacoeconomic analysis: a review of submissions to the Australian Pharmaceutical Benefits Scheme JO - JAMA VL - 283 UR - https://doi.org/10.1001/jama.283.16.2116 DO - 10.1001/jama.283.16.2116 ID - Hill2000 ER - TY - STD TI - Brita Pekarsky Working Paper presented to CGKD. 2006. ID - ref60 ER - TY - JOUR AU - Stocker, H. AU - Waitzkin, H. AU - Iriart, C. PY - 1999 DA - 1999// TI - 'The Exportation of Managed Care to Latin America,' JO - New England Journal of Medicine VL - 340 UR - https://doi.org/10.1056/NEJM199904083401425 DO - 10.1056/NEJM199904083401425 ID - Stocker1999 ER - TY - JOUR AU - Kaplan, R. L. PY - 2005 DA - 2005// TI - 'Who's Afraid of personal responsibility? Health savings accounts and the future of American health care' JO - McGeorge Law Review VL - 36 ID - Kaplan2005 ER - TY - BOOK PY - 2004 DA - 2004// TI - Pharmaceutical Price Controls in OECD Countries. Implications for US Consumers, Pricing, Research and Development and Innovation Washington DC ID - ref63 ER - TY - JOUR AU - Blumenthal, D. AU - Hsiao, W. PY - 2005 DA - 2005// TI - "Privatisation and its Discontents-The Evolving Chinese Health Care System" JO - New England Journal of Medicine VL - 353 UR - https://doi.org/10.1056/NEJMhpr051133 DO - 10.1056/NEJMhpr051133 ID - Blumenthal2005 ER - TY - JOUR AU - Barr, M. D. PY - 2001 DA - 2001// TI - "Medical Savings Accounts in Singapore: A Critical Inquiry" JO - J Health Polit Policy Law VL - 26 UR - https://doi.org/10.1215/03616878-26-4-709 DO - 10.1215/03616878-26-4-709 ID - Barr2001 ER - TY - CHAP AU - Will, D. e. l. a. a. t. PY - 2005 DA - 2005// TI - PBS Reform for a Healthy Australia BT - Address by Chairman, Medicines Australia. National Press Club, 3 ID - Will2005 ER - TY - CHAP PY - 2005 DA - 2005// TI - Human Development Report 2005 BT - United Nations Development Programme New York ID - ref67 ER - TY - STD TI - Foundation for Taxpayer and Consumer Rights[http://www.consumerwatchdog.org/pr/?postId=5512] UR - http://www.consumerwatchdog.org/pr/?postId=5512 ID - ref68 ER - TY - JOUR AU - Moynihan, R. PY - 2003 DA - 2003// TI - US politicians want federal funding to discover cost effectiveness of new drugs JO - British Medical Journal VL - 327 UR - https://doi.org/10.1136/bmj.327.7416.642 DO - 10.1136/bmj.327.7416.642 ID - Moynihan2003 ER - TY - CHAP AU - Shiner, J. PY - 2004 DA - 2004// TI - Evidence to Committee on Finance Subcommittees on Health Care and International Trade BT - United States Senate, Washington ID - Shiner2004 ER - TY - BOOK PY - 2004 DA - 2004// TI - Pharmaceutical Price Controls in OECD Countries. Implications for US Consumers, Pricing, Research and Development and Innovation Washington DC ID - ref71 ER - TY - STD TI - The so-called "TRIPS Agreement" is Annex 1C of the 1994 Marrakesh Agreement Establishing the World Trade Organisation. All relevant texts are published by the WTO (on line and in hard-copy with Cambridge University Press 1994) as The Legal Texts: The Results of the Uruguay Round of Multilateral Trade Negotiations. ID - ref72 ER - TY - STD TI - Communication from the United States, Scope and Modalities of Non-Violation Complaints Under the TRIPS Agreement, (IP/C/W/194). ID - ref73 ER - TY - STD TI - Professor P Drahos, personal communication. 2005. ID - ref74 ER - TY - STD TI - Davies P:Deputy Secretary, Australian Department of Health and Ageing. AUSFTA Conference. Health Impacts. [last accessed 4 January 2006] [http://www.apec.org.au/docs/fta04Davies.pdf] UR - http://www.apec.org.au/docs/fta04Davies.pdf. ID - ref75 ER - TY - STD TI - Scherer P: Head Health Division.Delegates to the OECD Group on Health[letter] Pharmaceutical Pricing Policy. Organisation for Economic Co-Operation and Development 20 September 2005 ID - ref76 ER - TY - CHAP PY - 1994 DA - 1994// BT - Guidelines for economic evaluations of pharmaceuticals: Canada PB - CCOHTA CY - Ottawa ID - ref77 ER - TY - CHAP PY - 2005 DA - 2005// TI - The Influence of the Pharmaceutical Industry BT - London; The Stationery Office Limited ID - ref78 ER -